Osimertinib (Tagrisso; AstraZeneca) is FDA approved for 3 unique cancer indications.
Robert Mownn, PharmD
Advertisement
Articles by Robert Mownn, PharmD
An emerging focus is aligning targeted, safe, and effective therapies with patient goals.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Estradiol-Containing MHT May Impact Alzheimer Disease-Related Biomarkers in Postmenopausal Women
2
CHEST 2025: Improving Access to Chronic Cough Treatment Through a Digital Therapeutic Solution
3
MHT Use Can Affect Cognitive Health Depending on Administration Method
4
CHEST 2025: Exploring the Link Between GLP-1 Receptor Agonists, Type 2 Diabetes, and Asthma Risk
5
